AurkA allosteric-IN-1
AurkA allosteric-IN-1 (compound 6h) is an Aurora A (AurkA) inhibitor (IC50: 6.50 μM) that inhibits the catalytic activity and non-catalytic functions of Aurora A. Aurora A regulates the assembly of the bipolar mitotic spindle and the fidelity of chromosome segregation during mitosis and has non-catalytic functions. AurkA allosteric-IN-1 blocks the interaction of AurkA with the activator TPX2 by binding to the Y pocket of AurkA[1].
Product Specifications
UNSPSC
12352005
Target
Aurora Kinase; Mitosis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage; Epigenetics
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/aurka-allosteric-in-1.html
Solubility
10 mM in DMSO
Smiles
O=C(C1=CC=CC(C2=CC=NC=C2)=C1)NCC3=CC4=C(OCO4)C=C3
Molecular Formula
C20H16N2O3
Molecular Weight
332.35
References & Citations
[1]Lee H, et al. Discovery of N-benzylbenzamide-based allosteric inhibitors of Aurora kinase A. Bioorg Med Chem. 2024 Mar 15;102:117658.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
Aurora A
Explore Other Products
Browse additional items from our catalog
PXDC1 Lentiviral Vector (Human) (CMV) (pLenti-GIII-CMV-RFP-2A-Puro)
Lentiviral human RAI14 sgRNA gene knockout kit - Lentiviral human RAI14 sgRNA gene knockout kit (plasmid)
Biotinylated Anti-GDF15 antibody (DMC474) ; IgG1 Chimeric mAb
